// company-profile

CytomX Therapeutics, Inc.

CTMX
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings91Insiders14
// api This CytomX Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 7 insiders purchased shares versus 1 sale. Buying was led by Ashworth Alan.

// 90-day insight

Over the last 90 days, CytomX Therapeutics, Inc. insiders bought $0 (7 transactions) and sold $5K (1 transaction).

  • Most active insider: Ogden Christopher with 1 transaction totaling $5K.
  • Largest single sale: $5K by Ogden Christopher on Jun 15, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of CytomX Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$913.7M
QoQ change
+52.5%
Reporting period
2026-03-31
#1
FMR LLC
CIK 315066
$123.7M
26.3M shares
#2
Kynam Capital Management, LP
CIK 1907884
$70.6M
15.0M shares
#3
PERCEPTIVE ADVISORS LLC
CIK 1224962
$47.5M
10.1M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 17, 2026Ashworth AlanCTMX
Award
59,000$0.00$0K
Jun 17, 2026Young Matthew P.CTMX
Award
59,000$0.00$0K
Jun 17, 2026Su ZhenCTMX
Award
59,000$0.00$0K
Jun 17, 2026Gilbert Halley ECTMX
Award
59,000$0.00$0K
Jun 17, 2026Meyers James RCTMX
Award
59,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.